Our data shows that the TGFβ-TGFβR and EGFR-NRG1 interaction revealing a cross-talk between the CAFs and CT26 tumor cells, which changes the expression of EGFR consequentially transforming the tumor cells (Figures 5A, B). The gene discussed is EGFR; the disease is neoplasm.